How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Buy
58
WGS Quote, Financials, Valuation and Earnings
Last price:
$79.58
Seasonality move
:
51.28%
Day range:
$76.70 - $81.90
52-week range:
$2.47 - $89.11
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.65x
P/B ratio:
10.40x
Volume:
138.8K
Avg. volume:
535K
1-year change:
2513.49%
Market cap:
$2.1B
Revenue:
$202.6M
EPS (TTM):
-$3.11
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings
|
$65M | -$0.22 | 39.72% | -86.89% | -- |
|
DRIO
DarioHealth
|
$7.4M | -$0.18 | 104.95% | -60.98% | -- |
|
FOXO
FOXO Technologies
|
-- | -- | -- | -- | -- |
|
OTRK
Ontrak
|
$2.6M | -- | -13% | -- | -- |
|
SPOK
Spok Holdings
|
$34.3M | $0.24 | 4.56% | 18.18% | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
WGS
GeneDx Holdings
|
$77.40 | -- | $2.1B | -- | $0.00 | 0% | 7.65x |
|
DRIO
DarioHealth
|
$0.70 | -- | $23.9M | -- | $0.00 | 0% | 1.09x |
|
FOXO
FOXO Technologies
|
$0.25 | -- | $4.3M | -- | $0.00 | 0% | 1.85x |
|
OTRK
Ontrak
|
$1.45 | -- | $6.1M | -- | $0.00 | 0% | 0.50x |
|
SPOK
Spok Holdings
|
$15.96 | -- | $323.5M | 21.86x | $0.31 | 7.83% | 2.37x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
WGS
GeneDx Holdings
|
20.28% | -5.208 | 4.47% | 2.00x |
|
DRIO
DarioHealth
|
33.03% | 1.132 | 82.25% | 1.27x |
|
FOXO
FOXO Technologies
|
224.55% | 16.543 | 1241.69% | 0.06x |
|
OTRK
Ontrak
|
40.88% | 4.227 | 95.85% | 0.98x |
|
SPOK
Spok Holdings
|
-- | 0.265 | -- | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
WGS
GeneDx Holdings
|
$47.8M | -$7.8M | -32.02% | -38.37% | -10.12% | -$5M |
|
DRIO
DarioHealth
|
$3.9M | -$12M | -49.97% | -71.65% | -162.06% | -$7.4M |
|
FOXO
FOXO Technologies
|
$655K | -$1.1M | -- | -- | -83.28% | $576K |
|
OTRK
Ontrak
|
$1.6M | -$5.1M | -149.3% | -231.34% | -198.72% | -$1.4M |
|
SPOK
Spok Holdings
|
$27.7M | $5.3M | 9.13% | 9.13% | 15.31% | $10.3M |
GeneDx Holdings vs. Competitors
-
Which has Higher Returns WGS or DRIO?
DarioHealth has a net margin of -10.81% compared to GeneDx Holdings's net margin of -166.11%. GeneDx Holdings's return on equity of -38.37% beat DarioHealth's return on equity of -71.65%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings62.22% -$0.31 $256.5M DRIODarioHealth52.23% -$0.25 $87.4M -
What do Analysts Say About WGS or DRIO?
GeneDx Holdings has a consensus price target of --, signalling upside risk potential of 4.44%. On the other hand DarioHealth has an analysts' consensus of -- which suggests that it could grow by 400.07%. Given that DarioHealth has higher upside potential than GeneDx Holdings, analysts believe DarioHealth is more attractive than GeneDx Holdings.
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings2 2 0 DRIODarioHealth3 0 0 -
Is WGS or DRIO More Risky?
GeneDx Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.468, suggesting its more volatile than the S&P 500 by 46.822%.
-
Which is a Better Dividend Stock WGS or DRIO?
GeneDx Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WGS or DRIO?
GeneDx Holdings quarterly revenues are $76.9M, which are larger than DarioHealth quarterly revenues of $7.4M. GeneDx Holdings's net income of -$8.3M is higher than DarioHealth's net income of -$12.3M. Notably, GeneDx Holdings's price-to-earnings ratio is -- while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings is 7.65x versus 1.09x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings7.65x -- $76.9M -$8.3M DRIODarioHealth1.09x -- $7.4M -$12.3M
-
Which has Higher Returns WGS or FOXO?
FOXO Technologies has a net margin of -10.81% compared to GeneDx Holdings's net margin of -162.71%. GeneDx Holdings's return on equity of -38.37% beat FOXO Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings62.22% -$0.31 $256.5M FOXOFOXO Technologies54.77% -$0.15 $14M -
What do Analysts Say About WGS or FOXO?
GeneDx Holdings has a consensus price target of --, signalling upside risk potential of 4.44%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that GeneDx Holdings has higher upside potential than FOXO Technologies, analysts believe GeneDx Holdings is more attractive than FOXO Technologies.
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings2 2 0 FOXOFOXO Technologies0 0 0 -
Is WGS or FOXO More Risky?
GeneDx Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock WGS or FOXO?
GeneDx Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WGS or FOXO?
GeneDx Holdings quarterly revenues are $76.9M, which are larger than FOXO Technologies quarterly revenues of $1.2M. GeneDx Holdings's net income of -$8.3M is lower than FOXO Technologies's net income of -$1.9M. Notably, GeneDx Holdings's price-to-earnings ratio is -- while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings is 7.65x versus 1.85x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings7.65x -- $76.9M -$8.3M FOXOFOXO Technologies1.85x -- $1.2M -$1.9M
-
Which has Higher Returns WGS or OTRK?
Ontrak has a net margin of -10.81% compared to GeneDx Holdings's net margin of -217.21%. GeneDx Holdings's return on equity of -38.37% beat Ontrak's return on equity of -231.34%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings62.22% -$0.31 $256.5M OTRKOntrak62.05% -$1.77 $19.4M -
What do Analysts Say About WGS or OTRK?
GeneDx Holdings has a consensus price target of --, signalling upside risk potential of 4.44%. On the other hand Ontrak has an analysts' consensus of -- which suggests that it could grow by 175.86%. Given that Ontrak has higher upside potential than GeneDx Holdings, analysts believe Ontrak is more attractive than GeneDx Holdings.
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings2 2 0 OTRKOntrak0 0 0 -
Is WGS or OTRK More Risky?
GeneDx Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ontrak has a beta of 2.569, suggesting its more volatile than the S&P 500 by 156.857%.
-
Which is a Better Dividend Stock WGS or OTRK?
GeneDx Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WGS or OTRK?
GeneDx Holdings quarterly revenues are $76.9M, which are larger than Ontrak quarterly revenues of $2.6M. GeneDx Holdings's net income of -$8.3M is lower than Ontrak's net income of -$5.6M. Notably, GeneDx Holdings's price-to-earnings ratio is -- while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings is 7.65x versus 0.50x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings7.65x -- $76.9M -$8.3M OTRKOntrak0.50x -- $2.6M -$5.6M
-
Which has Higher Returns WGS or SPOK?
Spok Holdings has a net margin of -10.81% compared to GeneDx Holdings's net margin of 10.5%. GeneDx Holdings's return on equity of -38.37% beat Spok Holdings's return on equity of 9.13%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings62.22% -$0.31 $256.5M SPOKSpok Holdings79.54% $0.18 $156.3M -
What do Analysts Say About WGS or SPOK?
GeneDx Holdings has a consensus price target of --, signalling upside risk potential of 4.44%. On the other hand Spok Holdings has an analysts' consensus of -- which suggests that it could fall by -6.02%. Given that GeneDx Holdings has higher upside potential than Spok Holdings, analysts believe GeneDx Holdings is more attractive than Spok Holdings.
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings2 2 0 SPOKSpok Holdings0 0 0 -
Is WGS or SPOK More Risky?
GeneDx Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.334, suggesting its less volatile than the S&P 500 by 66.63%.
-
Which is a Better Dividend Stock WGS or SPOK?
GeneDx Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.83% to investors and pays a quarterly dividend of $0.31 per share. GeneDx Holdings pays -- of its earnings as a dividend. Spok Holdings pays out 163.68% of its earnings as a dividend.
-
Which has Better Financial Ratios WGS or SPOK?
GeneDx Holdings quarterly revenues are $76.9M, which are larger than Spok Holdings quarterly revenues of $34.9M. GeneDx Holdings's net income of -$8.3M is lower than Spok Holdings's net income of $3.7M. Notably, GeneDx Holdings's price-to-earnings ratio is -- while Spok Holdings's PE ratio is 21.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings is 7.65x versus 2.37x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings7.65x -- $76.9M -$8.3M SPOKSpok Holdings2.37x 21.86x $34.9M $3.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
60
QMCO alert for Dec 27
Quantum [QMCO] is up 49.62% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is up 10.88% over the past day.
